P-164 Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma HENT1 positive: back to the future
- Resource Type
- Source
- Annals of Oncology. 26:iv47
- Subject
Oncology medicine.medical_specialty FOLFIRINOX business.industry Hematology medicine.disease Gemcitabine Internal medicine medicine Adenocarcinoma In patient business medicine.drug - Language
- ISSN
- 0923-7534